NEW YORK (GenomeWeb News) – Genetic Technologies today said that it has reached a settlement with Roche 454 Life Sciences over alleged infringement of Genetic Technologies' primary non-coding DNA patent.

The Australian firm said that it has reached a settlement, covenant, and license agreement with 454, which also covers its affiliates within Roche. The terms of the agreement are confidential.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Ancient DNA indicates Stone Age, hunter-gather inhabitants of Britain imported wheat.

Joel Achenbach explores at National Geographic why people find science difficult to believe.

In Science this week: gene linked to expansion of the human neocortex, and more.

The National Institute of General Medical Sciences director says changes the agency made have allow it to boost success rates.